{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:35:48Z","timestamp":1768282548441,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1208\/s12249-019-1408-x","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T20:18:17Z","timestamp":1559074697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Nanostructured Lipid Carrier of Propofol: a Promising Alternative to Marketed Soybean Oil\u2013Based Nanoemulsion"],"prefix":"10.1208","volume":"20","author":[{"given":"Ganesh","family":"Shevalkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Vavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijpharm.2012.01.011","volume":"425","author":"G Li","year":"2012","unstructured":"Li G, Fan Y, Li X, Wang X, Li Y, Liu Y, et al. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. Int J Pharm Elsevier. 2012;425:53\u201361.","journal-title":"Int J Pharm"},{"key":"1408_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijpharm.2012.07.008","volume":"436","author":"W Cai","year":"2012","unstructured":"Cai W, Deng W, Yang H, Chen X, Jin F. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics. Int J Pharm. 2012;436:536\u201344.","journal-title":"Int J Pharm"},{"key":"1408_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s12272-010-0911-0","volume":"33","author":"J Cho","year":"2010","unstructured":"Cho J, Cho JC, Lee P, Lee M, Oh E. Formulation and evaluation of an alternative triglyceride-free propofol microemulsion. Arch Pharm Res Pharmaceutical Society of Korea. 2010;33:1375\u201387.","journal-title":"Arch Pharm Res"},{"key":"1408_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/00000542-200510000-00026","volume":"103","author":"MT Baker","year":"2005","unstructured":"Baker MT, Naguib M. Propofol the challenges of formulation. Anesthesiol. 2005;103:860\u201376.","journal-title":"Anesthesiol"},{"key":"1408_CR5","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1021\/la401864p","volume":"29","author":"R Kaur","year":"2013","unstructured":"Kaur R, Kumar S, Aswal VK, Mahajan RK. Influence of headgroup on the aggregation and interactional behavior of twin-tailed cationic surfactants with pluronics. Langmuir American Chemical Society. 2013;29:11821\u201333.","journal-title":"Langmuir"},{"key":"1408_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/bja\/aeq059","volume":"104","author":"TD Egan","year":"2010","unstructured":"Egan TD. Exploring the frontiers of propofol formulation strategy: is there life beyond the milky way? Br J Anaesth. 2010;104:533\u20135.","journal-title":"Br J Anaesth"},{"key":"1408_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00000539-200107000-00023","volume":"93","author":"IT Cohen","year":"2001","unstructured":"Cohen IT, Hannallah RS, Goodale DB. The clinical and biochemical effects of propofol infusion with and without EDTA for maintenance anesthesia in healthy children undergoing ambulatory surgery. Anesth Analg. 2001;93:106\u201311.","journal-title":"Anesth Analg"},{"key":"1408_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/00000542-200405000-00027","volume":"100","author":"MT Baker","year":"2004","unstructured":"Baker MT, Gregerson MS, Naguib M. Role of lipid in sulfite-dependent propofol dimerization. Anesthesiology. 2004;100:1235\u201341.","journal-title":"Anesthesiology"},{"key":"1408_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/01.CCM.0000053560.05156.73","volume":"31","author":"MT Baker","year":"2003","unstructured":"Baker MT, Gregerson MS, Martin SM, Buettner GR. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite*. Crit Care Med. 2003;31:787\u201392.","journal-title":"Crit Care Med"},{"key":"1408_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00000542-200302000-00009","volume":"98","author":"P Rieschke","year":"2003","unstructured":"Rieschke P, LaFleur BJ, Janicki PK. Effects of EDTA- and sulfite-containing formulations of propofol on respiratory system resistance after tracheal intubation in smokers. Anesthesiol J Am Soc Anesthesiol The American Society of Anesthesiologists. 2003;98:323\u20138.","journal-title":"Anesthesiol"},{"key":"1408_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/bja\/aen147","volume":"101","author":"F Ravenelle","year":"2008","unstructured":"Ravenelle F, Vachon P, Rigby-Jones AE, Sneyd JR, Le Garrec D, Gori S, et al. Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation. Br J Anaesth. 2008;101:186\u201393.","journal-title":"Br J Anaesth"},{"key":"1408_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11095-007-9471-5","volume":"25","author":"F Ravenelle","year":"2008","unstructured":"Ravenelle F, Gori S, Le Garrec D, Lessard D, Luo L, Palusova D, et al. Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics. Pharm Res. 2008;25:313\u20139.","journal-title":"Pharm Res"},{"key":"1408_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1208\/s12249-007-9023-7","volume":"9","author":"AA Date","year":"2008","unstructured":"Date AA, Nagarsenker MS. Design and evaluation of microemulsions for improved parenteral delivery of propofol. AAPS PharmSciTech. 2008;9:138\u201345.","journal-title":"AAPS PharmSciTech"},{"key":"1408_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1208\/s12249-016-0524-0","volume":"18","author":"SS Darandale","year":"2017","unstructured":"Darandale SS, Shevalkar GB, Vavia PR. Effect of lipid composition in propofol formulations: decisive component in reducing the free propofol content and improving pharmacodynamic profiles. AAPS PharmSciTech. 2017;18:441\u201350.","journal-title":"AAPS PharmSciTech"},{"key":"1408_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00214-007-0288-4","volume":"119","author":"GM Jensen","year":"2008","unstructured":"Jensen GM, Ashvar CS, Bunte SW, Barzak CD, Bunch TH, Fahrner RL, et al. A liposomal dispersion formulation of propofol: formulation, pharmacokinetics, stability, and identification of an oxidative degradant. Theor Chem Accounts. 2008;119:291\u20136.","journal-title":"Theor Chem Accounts"},{"key":"1408_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/js970178s","volume":"87","author":"G Trapani","year":"1998","unstructured":"Trapani G, Latrofa A, Franco M, Lopedota A, Sanna E, Liso G. Inclusion complexation of propofol with 2-hydroxypropyl-\u03b2- cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. J Pharm Sci. 1998;87:514\u20138.","journal-title":"J Pharm Sci"},{"key":"1408_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/js960213f","volume":"86","author":"T Irie","year":"1997","unstructured":"Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci Elsevier. 1997;86:147\u201362.","journal-title":"J Pharm Sci"},{"key":"1408_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1517\/13543780903193063","volume":"18","author":"J Fechner","year":"2009","unstructured":"Fechner J, Ihmsen H, Jeleazcov C, Sch\u00fcttler J. Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol). Expert Opin Investig Drugs Taylor & Francis. 2009;18:1565\u201371.","journal-title":"Expert Opin Investig Drugs"},{"key":"1408_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/bja\/aeq040","volume":"104","author":"JA Jung","year":"2010","unstructured":"Jung JA, Choi BM, Cho SH, Choe SM, Ghim JL, Lee HM, et al. Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under total intravenous anaesthesia. Br J Anaesth Elsevier. 2010;104:563\u201376.","journal-title":"Br J Anaesth"},{"key":"1408_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.anclin.2014.02.003","volume":"32","author":"MS Melton","year":"2014","unstructured":"Melton MS, Nielsen KC, Tucker M, Klein SM, Gan TJ. New medications and techniques in ambulatory anesthesia. Anesthesiol Clin Elsevier. 2014;32:463\u201385.","journal-title":"Anesthesiol Clin"},{"key":"1408_CR21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/00000542-199809000-00018","volume":"89","author":"S Dutta","year":"1998","unstructured":"Dutta S, Ebling WF. Formulation-dependent brain and lung distribution kinetics of propofol in rats. J Am Soc Anesthesiol. 1998;89:678\u201385.","journal-title":"J Am Soc Anesthesiol"},{"key":"1408_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejpb.2008.09.003","volume":"71","author":"MD Joshi","year":"2009","unstructured":"Joshi MD, M\u00fcller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm Elsevier. 2009;71:161\u201372.","journal-title":"Eur J Pharm Biopharm"},{"key":"1408_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1208\/s12249-011-9733-8","volume":"13","author":"A Chinsriwongkul","year":"2012","unstructured":"Chinsriwongkul A, Chareanputtakhun P, Ngawhirunpat T, Rojanarata T, Sila-on W, Ruktanonchai U, et al. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS PharmSciTech. 2012;13:150\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"1408_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","volume":"47","author":"S Das","year":"2012","unstructured":"Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci Elsevier. 2012;47:139\u201351.","journal-title":"Eur J Pharm Sci"},{"key":"1408_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","volume":"56","author":"SA Wissing","year":"2004","unstructured":"Wissing SA, Kayser O, M\u00fcller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56:1257\u201372.","journal-title":"Adv Drug Deliv Rev"},{"key":"1408_CR26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1213\/00000539-200210000-00024","volume":"95","author":"HJ Theilen","year":"2002","unstructured":"Theilen HJ, Adam S, Albrecht MD, Ragaller M. Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg. 2002;95:923\u20139.","journal-title":"Anesth Analg"},{"key":"1408_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0973-8398.134921","volume":"8","author":"H Thakkar","year":"2014","unstructured":"Thakkar H, Desai J, Parmar M. Application of Box-Behnken design for optimization of formulation parameters for nanostructured lipid carriers of candesartan cilexetil. Asian J Pharm IEEE. 2014;8:81\u20139.","journal-title":"Asian J Pharm IEEE"},{"key":"1408_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.colsurfb.2012.08.058","volume":"102","author":"X Huang","year":"2013","unstructured":"Huang X, Chen Y-J, Peng D-Y, Li Q-L, Wang X-S, Wang D-L, et al. Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids Surf B: Biointerfaces Elsevier. 2013;102:391\u20137.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1408_CR29","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/jps.20627","volume":"95","author":"K Amin","year":"2006","unstructured":"Amin K, Dannenfelser R-M. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci. 2006;95:1173\u20136.","journal-title":"J Pharm Sci"},{"key":"1408_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Prog Biomed. 2010;99:306\u201314.","journal-title":"Comput Methods Prog Biomed"},{"key":"1408_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ijpharm.2013.03.034","volume":"454","author":"H Shete","year":"2013","unstructured":"Shete H, Patravale V. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Int J Pharm. 2013;454:573\u201383.","journal-title":"Int J Pharm"},{"key":"1408_CR32","first-page":"24","volume":"6","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, Harnisch S. Physicochemical characterization of propofol-loaded emulsions and interaction with plasma proteins. Eur Hosp Pharm. 2000;6:24\u201331.","journal-title":"Eur Hosp Pharm"},{"key":"1408_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","volume":"21","author":"RG Strickley","year":"2004","unstructured":"Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21:201\u201330.","journal-title":"Pharm Res"},{"key":"1408_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijpharm.2007.12.015","volume":"355","author":"W-G Dai","year":"2008","unstructured":"Dai W-G, Dong LC, Li S, Deng Z. Combination of pluronic\/vitamin E TPGS as a potential inhibitor of drug precipitation. Int J Pharm Elsevier. 2008;355:31\u20137.","journal-title":"Int J Pharm"},{"key":"1408_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.colsurfb.2017.03.006","volume":"154","author":"V Kaithwas","year":"2017","unstructured":"Kaithwas V, Dora CP, Kushwah V, Jain S. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability. Colloids Surf B: Biointerfaces. 2017;154:10\u201320.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1408_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1461-5347(99)00141-8","volume":"2","author":"AG Floyd","year":"1999","unstructured":"Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today. 1999;2:134\u201343.","journal-title":"Pharm Sci Technol Today"},{"key":"1408_CR37","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1208\/s12249-010-9521-x","volume":"11","author":"WJ Lambert","year":"2010","unstructured":"Lambert WJ. Considerations in developing a target product profile for parenteral pharmaceutical products. AAPS PharmSciTech Springer. 2010;11:1476\u201381.","journal-title":"AAPS PharmSciTech"},{"key":"1408_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/bja\/67.3.281","volume":"67","author":"W Klement","year":"1991","unstructured":"Klement W, Arndt JO. Pain on injection of propofol: effects of concentration and diluent. Br J Anaesth. 1991;67:281\u20134.","journal-title":"Br J Anaesth"},{"key":"1408_CR39","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1208\/s12249-010-9526-5","volume":"11","author":"K Hippalgaonkar","year":"2010","unstructured":"Hippalgaonkar K, Majumdar S, Kansara V. Injectable lipid emulsions\u2014advancements, opportunities and challenges. AAPS PharmSciTech. 2010;11:1526\u201340.","journal-title":"AAPS PharmSciTech"},{"key":"1408_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1046\/j.1365-2044.1998.00405.x","volume":"53","author":"CH Tan","year":"1998","unstructured":"Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia. John Wiley & Sons, Ltd (10.1111). 1998;53:468\u201376.","journal-title":"Anaesthesia"},{"key":"1408_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21767\/2386-5180.1000170","volume":"05","author":"AA Anzaku","year":"2017","unstructured":"Anzaku AA, Akyala JI, Juliet A, Obianuju EC. Antibacterial activity of lauric acid on some selected clinical isolates. Ann Clin Lab Res. 2017;05:1\u20135.","journal-title":"Ann Clin Lab Res"},{"key":"1408_CR42","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.archoralbio.2011.01.011","volume":"56","author":"CB Huang","year":"2011","unstructured":"Huang CB, Alimova Y, Myers TM, Ebersole JL. Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms. Arch Oral Biol. 2011;56:650\u20134.","journal-title":"Arch Oral Biol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1408-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T19:37:59Z","timestamp":1663529879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1408-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1408-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"201"}}